Related Experiment Video
Updated: Sep 28, 2026

Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging
Published on: January 30, 2026
Nanoparticle-Based Tools to Study Hallmarks of Aging at the Molecular Level
Shuai Yao1, Guangxun Shen1, Jingmin Zhao1
1Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.
Abstract:
Aging is characterized by the cumulative damage to the genome, proteome, epigenome, and organelles, which ultimately leads to telomere attrition, loss of proteostasis, genomic instability, mitochondrial dysfunction, cellular senescence, altered intracellular communication, chronic inflammation, and dysregulated nutrient sensing. Nanoparticle-based technologies are revolutionizing the ability to study the hallmark of aging at the molecular level. Due to the key limitation of conventional genomic, epigenomic, transcriptomic, proteomic, and metabolomic tools, nanoparticles play a vital role in the diagnosis and treatment of hallmarks of aging. This review aims to provide a comprehensive overview of recent progress on the role of nanoparticles and their applications in the diagnosis and treatment of aging and age-associated disease (AAD). In the first part of this review, we summarized aging and its hallmarks. Then, we described different types of molecular tools used in the diagnosis of aging and age-associated Diseases as well as their limitation. Finally, we reviewed the applications of each kind of nanoparticle with respect to the hallmarks. Collectively, this review provides the importance of nanoparticle platforms as a versatile toolbox to detect, visualize, and fine-tune aging hallmarks, connecting mechanistic studies with translational anti-aging interventions.
Related Concept Videos
Mitochondria
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
